Showing 1 - 6 results of 6 for search 'Hirokazu Tanino', query time: 0.03s
Refine Results
-
1
-
2
-
3
BRCAness as an Important Prognostic Marker in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy: A Multicenter Retrospective Study by Yoshimasa Kosaka, Yutaka Yamamoto, Hirokazu Tanino, Hiroshi Nishimiya, Mutsuko Yamamoto-Ibusuki, Yuko Hirota, Hirotaka Iwase, Seigo Nakamura, Sadako Akashi-Tanaka
Published 2020-02-01
Article -
4
Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer. by Naoko Minatani, Mina Waraya, Keishi Yamashita, Mariko Kikuchi, Hideki Ushiku, Ken Kojo, Akira Ema, Hiroshi Nishimiya, Yoshimasa Kosaka, Hiroshi Katoh, Norihiko Sengoku, Hirokazu Tanino, David Sidransky, Masahiko Watanabe
Published 2016-01-01
Article -
5
BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. by Hirokazu Tanino, Yoshimasa Kosaka, Hiroshi Nishimiya, Youko Tanaka, Naoko Minatani, Mariko Kikuchi, Akiko Shida, Mina Waraya, Hiroshi Katoh, Takumo Enomoto, Norihiko Sengoku, Sabine Kajita, Robert M Hoffman, Masahiko Watanabe
Published 2016-01-01
Article -
6
Randomized Controlled Trial of Zoledronic Acid plus Chemotherapy versus Chemotherapy Alone as Neoadjuvant Treatment of HER2-Negative Primary Breast Cancer (JONIE Study). by Yoshie Hasegawa, Hirokazu Tanino, Jun Horiguchi, Daishu Miura, Takashi Ishikawa, Mitsuhiro Hayashi, Shintaro Takao, Seung Jin Kim, Kazuhiko Yamagami, Masaru Miyashita, Muneharu Konishi, Yasushi Shigeoka, Masato Suzuki, Tetsuya Taguchi, Tomoyuki Kubota, Kouhei Akazawa, Norio Kohno, JONIE Study Group
Published 2015-01-01
Article